SACCANI, Francesca
 Distribuzione geografica
Continente #
EU - Europa 1.161
NA - Nord America 1.105
AS - Asia 554
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 2.840
Nazione #
US - Stati Uniti d'America 1.091
CN - Cina 445
FI - Finlandia 326
SE - Svezia 278
IE - Irlanda 236
IT - Italia 107
DE - Germania 71
UA - Ucraina 71
TR - Turchia 47
SG - Singapore 43
AT - Austria 29
CI - Costa d'Avorio 15
IN - India 15
CA - Canada 14
BE - Belgio 11
CZ - Repubblica Ceca 11
FR - Francia 9
EU - Europa 5
GB - Regno Unito 5
IR - Iran 2
RU - Federazione Russa 2
CH - Svizzera 1
HU - Ungheria 1
JP - Giappone 1
MD - Moldavia 1
NL - Olanda 1
RO - Romania 1
VN - Vietnam 1
Totale 2.840
Città #
Chandler 277
Dublin 236
Beijing 102
Jacksonville 99
Dearborn 96
Parma 81
Nanjing 65
Shanghai 60
Ashburn 54
New York 52
Ann Arbor 48
Izmir 44
Princeton 39
Boardman 29
Vienna 29
Wilmington 24
Nanchang 23
San Mateo 23
Kunming 20
Singapore 20
Hebei 19
Jinan 17
Bremen 16
Abidjan 15
Des Moines 15
Helsinki 15
Seattle 14
Hefei 13
Guangzhou 12
Brussels 11
Pune 11
Shenyang 11
Toronto 10
Brno 9
Changsha 9
Tianjin 9
Zhengzhou 9
Jiaxing 8
Norwalk 8
Hangzhou 7
Cagliari 4
Chengdu 4
Fremont 4
Woodbridge 4
Augusta 3
Chongqing 3
Dallas 3
Fuzhou 3
Genoa 3
Grafing 3
Houston 3
Kocaeli 3
Mantova 3
Munich 3
Rockville 3
Taizhou 3
Wenzhou 3
Düsseldorf 2
Gainesville 2
Haikou 2
Lanzhou 2
Manchester 2
Mestre 2
Montreal 2
Montréal 2
Olomouc 2
Redmond 2
Redwood City 2
Reggio Nell'emilia 2
Xian 2
Alchevs'k 1
Bangalore 1
Baotou 1
Bologna 1
Borås 1
Budapest 1
Cardiff 1
Castel Goffredo 1
Chicago 1
Chisinau 1
Focsani 1
Frankfurt am Main 1
Goose Creek 1
Hanoi 1
Huizen 1
Jamaica Plain 1
Langfang 1
Leawood 1
Los Angeles 1
Modena 1
Montegaldella 1
New Delhi 1
Ningbo 1
Old Bridge 1
Philadelphia 1
Sassuolo 1
Shaoxing 1
Spezzano Albanese 1
Taiyuan 1
Tehran 1
Totale 1.770
Nome #
Effect of μ Opioid Receptor Activation On Intestinal Ischemia/Reperfusion Injury in Mice 101
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 100
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 96
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 94
Targeting PI3K somatic mutations reduces invasion and EMT in squamous cell carcinoma of the lung 93
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 91
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 88
Dual role of endogenous serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-induced colitis 87
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification 87
Gastrointestinal symptoms and local oxidative stress in a model of Parkinson's Disease in rats 87
Daily assumption of fermented milk containing Bifidobacterium breve 246 B® promotes prophylactic effects against intestinal inflammation in mice 86
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines 83
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 81
Erlotinib enhances antibody-dependent cellular cytotoxicity of wil-type erlotinib-sensitive NSCLC cell lines 81
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 81
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 80
Analgesic activity of new hybrid muscarinic agonists in mice 79
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 78
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 76
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 75
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 74
Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation. 74
Effect of specific PI3K/mTOR inhibitors in squamous lung cancer cells carrying PI3K alterations 73
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 72
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 72
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 68
5-HT1A receptors as target to protect the intestine in an experimental model of colitis 68
Activation of μ opioid receptors ameliorates mucosal injury induced by intestinal ischemia and reperfusion in mice 67
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer 66
Radiological analysis of gastrointestinal dysmotility associated with central dopaminergic impairment in an animal model of parkinson's disease (PD) 65
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced inflammatory injuries in mice 61
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 60
Pharmacological modulation of 5HT1A receptors in mice mesenteric ischemia/reperfusion injury: protective effect of Buspirone and WAY100135 57
Effects of FGFR1 inhibition on survival, proliferation, and energy metabolism in Non Small Cell Lung Cancer (NSCLC) cell lines 57
Protective role of μ opioid receptor activation in intestinal inflammation induced by mesenteric ischemia/reperfusion in mice. 51
T-DM1: a new therapeutic approach in HER-2 overexpressing NSCLC cell lines 46
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 45
Pharmacological characterization of a new non-himidazole histamine H3 antagonist 43
Investigation into the μ opioid receptor role in an experimental model of mesenteric ischemia/reperfusion 40
Totale 2.883
Categoria #
all - tutte 9.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.329


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020483 0 133 28 12 34 65 68 9 39 48 18 29
2020/2021153 1 19 7 1 20 2 20 0 36 14 33 0
2021/2022174 2 0 0 25 6 3 23 21 8 10 9 67
2022/2023984 119 132 62 85 81 113 24 38 271 2 46 11
2023/2024337 15 18 4 12 24 92 32 40 18 6 25 51
2024/202532 26 6 0 0 0 0 0 0 0 0 0 0
Totale 2.883